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Abstract There continues to be significant controversy
related to diagnostic testing for gastroesophageal reflux
disease (GERD). Clearly, barium contrast fluoroscopy is
superior to any other test in defining the anatomy of the
upper gastrointestinal (UGI) tract. Although fluoroscopy can
demonstrate gastroesophageal reflux (GER), this observa-
tion does not equate to GERD. Fluoroscopy time should not
be prolonged to attempt to demonstrate GER during barium
contrast radiography. There are no data to justify prolonging
fluoroscopy time to perform provocative maneuvers to
demonstrate reflux during barium contrast UGI series.
Symptoms of GERD may be associated with physio-
logic esophageal acid exposure measured by intraeso-
phageal pH monitoring, and a significant percentage of
patients with abnormal esophageal acid exposure have
no or minimal clinical symptoms of reflux. Abnormal
acid exposure defined by pH monitoring over a 24-h
period does not equate to GERD. In clinical practice
presumptive diagnosis of GERD is reasonably assumed
by substantial reduction or elimination of suspected
reflux symptoms during therapeutic trial of acid
reduction therapy.
Keywords Gastroesophageal reflux disease .
Gastroesophageal reflux
In review articles gastroesophageal reflux (GER) appears
to be a straightforward problem. In practice, however, there
continues to be significant controversy, particularly related
to diagnosis. GER is defined as the passage of gastric
contents into the esophagus. In infants and children reflux
may be thought of in one of three patterns. First,
intraesophageal pH monitoring in asymptomatic infants
and children has revealed that GER is a silent physiologic
phenomenon. If acid reflux is defined as a drop in
intraesophageal pH to less than 4 (a pH at which acid is
capable of producing tissue injury), the infant esophagus is
exposed to an acid environment for 11% and the child and
adolescent esophagus for 5–6% of a 24-h period [1]. Thus,
all infants and children reflux to some degree. Second,
reflux is a common clinical syndrome in infancy
manifested by recurrent vomiting or oral regurgitation. In
the first 6 months of life, 50–60% of infants vomit at least
once daily, and 15–20% more than four times daily [2].
That reflux in infancy is a developmental phenomenon is
supported by the rapid improvement in frequency of
symptoms between the ages of 6 and 12 months. By 1 year
of age, 5% of infants may still vomit once daily, but less
than 1% will vomit in excess of four times a day. Third,
when refluxed gastric contents produce clinical symptoms
or tissue damage, GER is called a disease, gastroesopha-
geal reflux disease (GERD). In most patients with GERD
there is an increased frequency of reflux or prolonged
exposure of the esophagus to an acid environment beyond
physiologic parameters. However, GERD may also occur
in patients with asymptomatic physiologic reflux [3].
The predominant mechanism of reflux in all three
patterns is the same: transient relaxation of the lower
esophageal sphincter (LES) [4]. The LES is believed to be
the major barrier to reflux in humans. It is termed a
physiologic sphincter because there is no anatomical
structure, such as the pylorus, at the gastroesophageal
junction. The smooth muscle in this area behaves as a
sphincter in that it maintains a basal tone greater than the
esophagus above or stomach below, and relaxes with
stimuli from above (swallow or esophageal distension).
Reflux is not caused by a weak sphincter, but rather a
sphincter that relaxes at times it should not. These transient
relaxations are not associated with any esophageal body
motor events. Triggers of transient relaxations described to
date include: (1) a vagovagal reflex initiated by gastric
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distension, (2) a subthreshold swallow that does not trigger
peristalsis, and (3) a vagovagal reflex initiated by cardio-
pulmonary receptors.
The symptoms of GERD may be classified as esopha-
geal or extraesophageal. In an infant with recurrent
vomiting or oral regurgitation the symptoms of esophageal
GERD include unexplained irritability, feeding difficulty,
poor weight gain, or sleep disturbance. In the older child
the symptoms may include chronic heartburn, epigastric
abdominal pain, oral regurgitation, episodic vomiting,
dysphagia, and rarely hematemesis. Heartburn and/or oral
regurgitation are reported to occur in 2% of children aged
3–9 years, in 5–8% of children aged 10–17 years, and in
20% of adults [5, 6]. The pathogenesis of esophageal
GERD is related to the exposure of the esophagus to gastric
contents (increased frequency of reflux and/or impaired
esophageal acid clearance), volume, potency, and height of
refluxed material, defective tissue resistance, reduced
esophageal capacitance, or heightened esophageal sensi-
tivity. The symptom of heartburn does not necessarily
mean esophagitis. A patient with heightened esophageal
sensitivity may have as much or more heartburn as a patient
with erosive esophagitis. Extraesophageal symptoms of
GERD include chronic cough, wheezing/asthma, apnea,
bradycardia, chronic sore throat, hoarseness, dental
erosions, and recurrent otitis/sinusitis [7]. The pathogenesis
of extraesophageal GERD may include: (1) regurgitation
into the oral pharynx or nasal passages causing direct
caustic injury, inflammation, edema, eustachian tube
dysfunction, or impaired sinus drainage; (2) microaspira-
tion resulting in direct caustic injury, inflammation, edema,
epithelial hypertrophy, laryngitis, pneumonitis, or vagal
reflex-mediated cough, laryngospasm, or bronchospasm;
or (3) stimulation of esophageal vagal afferent receptors
resulting in reflux-mediated change in airway resistance or
bronchial hyperreactivity.
Options for the treatment of GERD include lifestyle
changes, pharmacotherapy, and surgical therapy. Lifestyle
changes include avoiding overfeeding, thickened feeds,
upright positioning during sleep, and avoidance of second-
hand smoke. The obvious goal of pharmacotherapy would
be to reduce transient LES relaxations. However, to date,
there are no approved medications that target the actual
mechanism of reflux. Pharmacologic agents that have been
reported to decrease the frequency of transient relaxations
include atropine, cholecystokinin antagonist receptors,
nitric oxide synthase inhibitors, and GABA receptor
antagonists (e.g. baclofen). The goal of current pharmaco-
logic therapy of GERD is to reduce esophageal acid
exposure either by reducing gastric acid secretion or
enhancing GI motility to accelerate gastric emptying or
hasten esophageal acid clearance following reflux [3]. Both
histamine receptor antagonists (H2RAs, e.g. ranitidine,
famotidine, cimetidine, and nizatidine) and proton pump
inhibitors (PPIs, e.g. omeprazole, lansoprazole) have been
reported to be efficacious in the treatment of pediatric
GERD. Only in erosive esophagitis have PPIs been found
to be superior to H2RAs. Whereas the traditional approach
to acid-reducing therapy in adults is step down (begin
treatment with PPI → maintain improvement with PPI →
step down to an H2RA), the approach in children has
traditionally been step up (begin treatment with H2RA→ if
inadequate response step up to PPI → if inadequate
response increase PPI dose). As a general rule, there is no
evidence-based justification for the routine use of currently
available promotility agents (metoclopramide, bethanecol,
erythromycin) to treat GERD in children. The principles of
antireflux surgery include lengthening the intraabdominal
segment of the esophagus, approximating the diaphrag-
matic crura, and wrapping the gastric fundus around the
LES to reinforce the antireflux barrier. Unlike pharmaco-
therapy, antireflux surgery has been reported to decrease
the frequency of transient LES relaxations.
Several principles must be considered in choosing
GERD therapy. It is very important to identify outcome
variables before initiating therapy (i.e. heartburn, unex-
plained irritability in an infant, asthma outcome parameters
such as quality of life indexes, pulmonary function tests,
hospitalizations, need for steroids). Unlike esophageal
symptoms of GERD, extraesophageal symptoms require
higher doses of acid-reduction therapy for prolonged
periods (3–6 months) before assessing outcome variables
[8]. Finally, treatment requirements for the same esopha-
geal symptoms differ between individual patients. Many
patients require only situational medication (antacid over-
the-counter acid-reducing agents when eating spicy foods),
while others require more prolonged intermittent therapy
(2–8 weeks of acid-reducing agents), and still others
require continuous acid reducing agents.
Diagnosis of GERD
In clinical practice a presumptive diagnosis is reasonably
assumed by a substantial reduction or elimination of
suspected reflux symptoms during a therapeutic trial of
acid-reduction therapy. However, many clinicians prefer an
objective test to confirm a diagnosis of GERD in an infant
or child with chronic vomiting, symptoms that suggest
esophageal pain, or respiratory disease that is not
responding to the usual therapies. The presumptive diag-
nostic tests for GERD include barium contrast upper GI
series, intraesophageal pH monitoring, multichannel intra-
luminal impedance, scintigraphy of a technetium-sulfur
colloid test meal, and upper endoscopy with esophageal
biopsy to detect esophagitis. Intraesophageal pH monitor-
ing has long been considered the gold standard since the
test allows direct measurement of esophageal pH in
physiologic circumstances over many hours [9, 10].
Prolonged pH monitoring determines the frequency of
reflux and the percent time that the esophagus is exposed to
an acid environment over a defined time period, detects
silent reflux in the absence of vomiting or oral regurgita-
tion, assesses the height of reflux in the esophagus,
determines effectiveness of esophageal clearance mechan-
isms, determines if a temporal association between acid
reflux and symptoms exist, and assesses the adequacy of
H2RA or PPI dosage in unresponsive patients.
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With new wireless technology a pH probe can be
secured endoscopically into the esophageal wall to allow
continuous ambulatory monitoring over 48 h [11].
Prolonged intraesophageal pH monitoring has a high
specificity (about 95%) meaning that patients without
GERD are likely to have a negative test. In both adult and
pediatric patients with erosive esophagitis, pH monitoring
has a high sensitivity (90–95%). However, in adults with
symptoms of GERD but without gross endoscopic esoph-
agitis, the sensitivity of pH monitoring drops to about 50%
[12]. Approximately 40% of adults with symptoms of
chronic heartburn, acid regurgitation, chest pain, belching,
odynophagia, or pharyngeal pain will have a negative pH
probe study. Infants and children with GERD rarely have
visual changes of esophagitis at upper endoscopy. That pH
monitoring has a low sensitivity for diagnosing GERD in
the majority of pediatric patients is suggested by two
Scandinavian studies in which only 29–49% of asthmatic
children with clinical symptoms of GERD had positive pH
studies [13, 14]. These observations contrast with a number
of case series in which 50% of asthmatic children chosen to
undergo pH monitoring because of resistance to usual
pulmonary therapies had abnormal studies [10]. Thus, pH
monitoring teaches two major lessons: symptoms of GERD
may be associated with physiologic esophageal acid
exposure, and a significant percentage of patients with
abnormal esophageal acid exposure have no or minimal
clinical symptoms of reflux. The ongoing controversy is
whether such asymptomatic patients can have extraeso-
phageal symptoms that would respond to acid-reduction
therapy. More likely, abnormal acid exposure defined by
pH monitoring over a 24-h period does not equate to
GERD. There are also no data that pH studies allow the
clinician to accurately predict the prognosis of GERD
(natural history, risk of complications such as esophageal
stricture or Barrett esophagus).
Intraluminal impedance is a new technology based on
measuring changes in electrical conductivity between two
rings connected to an alternating current (AC) generator
[15]. Suspended in air the impedance catheter records high
impedance values. The ions in a bolus of liquid (i.e. gastric
contents) increase electrical conductivity and thereby
decrease impedance. The potential advantage of intralumi-
nal impedance measurements is the ability to detect non-
acidic GER episodes. However, normal values in pediatric
age groups have yet to be defined, analysis of tracings is
time-consuming, and portable devices are unavailable for
outpatient studies. Scintigraphy of a radiolabeled test meal
also has the ability to detect acidic and non-acidic GER in
the postprandial period as well as evaluate gastric emptying
and occasionally detect aspiration of gastric contents
during reflux. It too suffers from lack standardized
techniques and absence of age-specific normative data.
The Society of Pediatric Radiology Position Statement
in 1999 made two recommendations on the role of
fluoroscopy in evaluating vomiting: (1) the primary role
is to define whether there is a point of anatomic
abnormality, but (2) the radiologist should also note
whether there is GER, altered esophageal motility, or
delayed gastric emptying. Clearly, fluoroscopy is superior
to any other test in defining the anatomy of the upper GI
tract. Indications for UGI series include bilious vomiting,
forceful protracted vomiting, feeding difficulty/dysphagia,
unexplained poor weight gain/weight loss, to assess the status
of previous fundoplication, or simply to reassure the parent or
physician of a child with chronic vomiting. The controversy
lies in the role of fluoroscopy as a diagnostic test for GER.
Unlike pH monitoring, there is no standard methodology.
The volume of the barium meal varies, many times a
nasogastric tube must be used in infants or toddlers who
refuse to swallow barium, the duration for observation for
spontaneous reflux varies between radiologists, and there
is considerable variation between radiologists on the use
of provocative maneuvers to elicit reflux. Certainly,
extended observation or provocative maneuvers prolong
fluoroscopy time. The majority of adult case series where
pH monitoring is the standard for diagnosis report low
sensitivity (16–50%) and moderate specificity (77–94%)
of fluoroscopy for diagnosing reflux [16–19]. Provocative
maneuvers, including abdominal compression, Valsalva
maneuver, positional changes (upright, right lateral prone
oblique, rolling side to side), leg lifting, coughing and
water siphon test, improve sensitivity (44–92%), but
reduce specificity (0–75%) [16–19].
Pediatric case series have reported that reflux is
demonstrated at fluoroscopy in a large percentage of
infants and children who are studied for any reason. The
percentage of patients who have GER progressively
diminishes with age (about 80% of infants less than
18 months decreasing to about 30% of adolescents between
12 and 18 years of age) [20]. GER is present in a number of
children whose symptoms would not have suggested its
presence. Finally, although many radiologists use grading
systems to describe the height of reflux during fluoroscopy,
there is no correlation between height of reflux and
esophageal or extraesophageal symptoms of GERD, or
prognosis or natural history of reflux [20]. Thus, the results
of small case series evaluating fluoroscopy mimic the
results found with pH monitoring. Although there is no
doubt that fluoroscopy can demonstrate GER, this
observation does not equate to GERD. Fluoroscopy time
should not be prolonged to attempt to demonstrate GER
during barium contrast radiography. There are no data to
justify prolonging fluoroscopy time to perform provocative
maneuvers to demonstrate reflux during barium contrast
UGI series. It is important for radiologists to recognize how
profoundly descriptive radiology reports impact on clinical
management. Radiology reports should describe the
presence or absence of reflux, but clearly state that
demonstration of reflux during fluoroscopy does not
equate to GERD.
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